Reference : Gene therapy in liver diseases: State-of-the-art and future perspectives
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
http://hdl.handle.net/10993/27431
Gene therapy in liver diseases: State-of-the-art and future perspectives
English
Domvri, Kalliopi [Pulmonary Department-Oncology Unit, G. Papanikolaou General Hospital, Aristotle University of Thessaloniki, Greece]
Zarogoulidis, Paul [Pulmonary Department-Oncology Unit, G. Papanikolaou General Hospital, Aristotle University of Thessaloniki, Greece, Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece]
Porpodis, Konstantinos [Pulmonary Department-Oncology Unit, G. Papanikolaou General Hospital, Aristotle University of Thessaloniki, Greece]
Koffa, Maria mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit]
Lambropoulou, Maria [Laboratory of Histology/Embryology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece]
Kakolyris, Stylianos [Dept. Oncology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece]
Kolios, George [Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece]
Zarogoulidis, Konstantinos [Pulmonary Department-Oncology Unit, G. Papanikolaou General Hospital, Aristotle University of Thessaloniki, Greece]
Chatzaki, Ekaterini [Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece]
2012
Current Gene Therapy
12
6
463-483
Yes (verified by ORBilu)
International
15665232
[en] Gene therapy ; Hepatocellular ; Liver ; Metabolic disorder ; Vector ; DNA vaccine ; Wilson disease protein ; Crigler Najjar syndrome ; Epstein Barr virus ; Herpes simplex virus 1 ; Hurler syndrome ; Maroteaux Lamy syndrome ; Wilson disease ; Adenoviridae ; Animals ; Cell Line, Tumor ; Gene Transfer Techniques ; Genetic Diseases, Inborn ; Genetic Therapy ; Genetic Vectors ; Humans ; Liver Diseases ; Lysosomal Storage Diseases ; Mutation ; Oncolytic Virotherapy ; RNA Interference
[en] Gene therapy is a fundamentally novel therapeutic approach that involves introducing genetic material into target cells in order to fight or prevent disease. A number of different strategies of gene therapy are tested at experimental and clinical levels, including: a) replacing a mutated gene that causes disease with a healthy copy of the gene, b) inactivating a mutated gene that its improper function causes pathogenesis, c) introducing a new gene coding a therapeutic compound to fight a disease, d) introducing to the target organ an enzyme converting an inactive pro-drug to its cytotoxic metabolite. In gene therapy, the transcriptional machinery of the patient is used to produce the active factor that exerts the intended therapeutic effect, ideally in a permanent, tissue-specific and manageable way. The liver is a major target for gene therapy, presenting inherited metabolic defects of single-gene etiology, but also severe multifactorial pathologies with limited therapeutic options such as hepatocellular carcinoma. The initial promising results from gene therapy strategies in liver diseases were followed by skepticism on the actual clinical value due to specificity, efficacy, toxicity and immune limitations, but are recently re-evaluated due to progress in vector technology and monitoring techniques. The significant amount of experimental data along with the available information from clinical trials are systematically reviewed here and presented per pathological entity. Finally, future perspectives of gene therapy protocols in hepatology are summarized. © 2012 Bentham Science Publishers.
http://hdl.handle.net/10993/27431
10.2174/156652312803519788

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Gene Therapy in Liver Diseases.pdfPublisher postprint554.6 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.